Business Context and Reporting Period
Company: Universal Safety Products, Inc. (Ticker: UUU, NYSE American)
Filing Type: Form 8-K (Current Report)
Date of Report: August 13, 2025
Event: Entry into a Material Definitive Agreement for a convertible debt financing facility.
Key Financial Metrics and Transaction Terms
This filing details a financing arrangement rather than periodic financial performance metrics (revenue, profit, cash flow). Key transaction terms include:
- Total Facility Size: Up to $2,750,000 in aggregate principal amount of Convertible Notes.
- Total Purchase Price (Loan Amount): Up to $2,500,000.
- Initial Tranche (Closed Aug 13, 2025): $1,100,000 principal for a $1,000,000 purchase price (10% Original Issue Discount).
- Second Tranche: $550,000 principal for $500,000 purchase price (triggered upon SEC filing of Registration Statement).
- Third Tranche: $1,100,000 principal for $1,000,000 purchase price (triggered upon SEC effectiveness of Registration Statement and Stockholder Approval).
- Interest Rate: 8% per annum; increases to 20% per annum on amounts exceeding $500,000 in the event of default.
- Maturity: One year from issuance.
- Conversion Price: Greater of $1.00 (Floor Price) or 80% of the lowest VWAP of the 10 trading days prior to conversion, capped at $10.00 per share.
Material Changes and Covenants
The agreement imposes significant restrictions on the Company's capital structure and future financing activities:
- Issuance Lock-up: For 90 days from the Execution Date, the Company is prohibited from issuing or announcing the issuance of Common Stock or convertible instruments, with limited exceptions.
- Variable Rate Prohibition: The Company cannot enter into variable rate transactions for one year or until the Notes are no longer outstanding.
- Right of First Refusal: SJC Lending LLC holds a right of first refusal on all future public or private equity offerings and convertible debt for one year.
- Dilution Cap: Conversion is limited to 19.99% of outstanding shares as of the Execution Date unless Stockholder Approval is obtained.
Outlook, Risks, and Contingencies
Conditions Precedent: The full funding of the facility is contingent upon the filing and effectiveness of an SEC Registration Statement and the receipt of Stockholder Approval for issuances exceeding the 19.99% dilution threshold.
Risks:
- Default Risk: Failure to pay or deliver shares triggers a penalty interest rate of 20% on amounts over $500,000.
- Regulatory Risk: Conversion is subject to NYSE American approval of a Supplemental Listing Application (SLAP).
- Financing Restrictions: The 90-day lock-up and one-year right of first refusal may limit the Company's ability to raise capital from other sources.
Management Commentary: The filing does not contain explicit management commentary beyond the disclosure of the agreement terms.
Investor Verification Checklist
- Verify the current share count to assess the immediate dilution impact of the 19.99% cap.
- Confirm the status of the Registration Statement filing and the timeline for Stockholder Approval.
- Review the Company's current cash position to determine reliance on the remaining tranches for liquidity.
- Monitor the stock price relative to the $1.00 floor price and the 80% VWAP conversion formula.
- Check for any existing variable rate transactions that may conflict with the new covenant.